Petros Pharmaceuticals In... (PTPI)
0.29
-0.02 (-6.60%)
At close: Jan 15, 2025, 12:33 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -8.16M | -20.04M | -8.99M | -20.59M | -32.51M | -32.47M |
| Depreciation & Amortization | 3.42M | 5.60M | 6.88M | 6.66M | 5.29M | 8.06M |
| Stock-Based Compensation | 417.23K | 1.20M | 1.31M | n/a | n/a | n/a |
| Other Working Capital | 752.72K | -231.14K | -3.67M | -5.80M | 7.58M | 3.85M |
| Other Non-Cash Items | -4.08M | 3.75M | 186.82K | 2.02M | 11.90M | 42.55M |
| Deferred Income Tax | n/a | n/a | -9.48M | -1.43M | -645.87K | -6.94K |
| Change in Working Capital | 789.05K | -3.30M | -1.76M | -5.60M | 13.09M | 4.93M |
| Operating Cash Flow | -7.63M | -12.80M | -11.86M | -15.31M | 2.53M | 8.02M |
| Capital Expenditures | -1 | n/a | n/a | -4.63K | -71.54K | -1.88M |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | -4.63M | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | -4.63K | -71.54K | -1.88M |
| Debt Repayment | -1.46M | -1.62M | -7.19M | 8.78M | -3.11M | -2.55M |
| Common Stock Repurchased | -2.00M | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 13.00M | n/a | 4.01M | 21.52M | -2.90M | n/a |
| Financial Cash Flow | 11.54M | -1.62M | 18.57M | 30.30M | -3.11M | -2.55M |
| Net Cash Flow | 3.91M | -14.42M | 6.71M | 14.99M | -648.31K | 3.60M |
| Free Cash Flow | -7.63M | -12.80M | -11.86M | -15.31M | 2.46M | 6.15M |